(Q39714317)

14 September 2017

A profiling platform for the characterization of transglutaminase 2 (TG2) inhibitors (English)

1 reference

14 September 2017

Sabine Schaertl

1

1 reference

14 September 2017

Michael Prime

2

1 reference

14 September 2017

John Wityak

3

1 reference

14 September 2017

Celia Dominguez

4

1 reference

14 September 2017

Ignacio Munoz-Sanjuan

5

1 reference

14 September 2017

Robert E Pacifici

6

1 reference

14 September 2017

Stephen Courtney

7

1 reference

14 September 2017

Andreas Scheel

8

1 reference

14 September 2017

Douglas Macdonald

9

1 reference

14 September 2017

15 April 2010

1 reference

Journal of Biomolecular Screening

14 September 2017

1 reference

14 September 2017

15

1 reference

14 September 2017

5

1 reference

14 September 2017

478-487

1 reference

A novel function of tissue-type transglutaminase: protein disulphide isomerase

14 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F1087057110366035

Localization of transglutaminase in hippocampal neurons: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110366035

Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: identification of osteonectin as a major glutaminyl substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110366035

Role of tissue transglutaminase in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110366035

Tissue transglutaminase (TG2) in cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110366035

Transglutaminase 2 inhibitors and their therapeutic role in disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110366035

Transglutaminases and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110366035

'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110366035

Tissue transglutaminase contributes to disease progression in the R6/2 Huntington's disease mouse model via aggregate-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110366035

Mutations of keratinocyte transglutaminase in lamellar ichthyosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110366035

ETRO Working Party on Factor XIII questionnaire on congenital factor XIII deficiency in Europe: status and perspectives. Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110366035

Structure-activity relationship study of novel tissue transglutaminase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110366035

Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110366035

Transglutaminase 2 undergoes a large conformational change upon activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110366035

Evaluation of novel dipeptide-bound alpha,beta-unsaturated amides and epoxides as irreversible inhibitors of guinea pig liver transglutaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110366035

Transglutaminase activity is increased in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110366035

Type 2 transglutaminase differentially modulates striatal cell death in the presence of wild type or mutant huntingtin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110366035

The role of the informatics framework in early lead discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110366035

Nucleotide binding by the erythrocyte transglutaminase/Gh protein, probed with fluorescent analogs of GTP and GDP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110366035

Mechanism for the inhibition of transglutaminase 2 by cystamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110366035

Selective putrescine export is regulated by insulin and ornithine in Reuber H35 hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057110366035

21 January 2018

Identifiers

DOI

10.1177/1087057110366035

1 reference

14 September 2017

1 reference